摘要
心肌缺血通常导致一系列的代谢变化,通过改善缺血心肌的代谢和心肌功能,可治疗缺血性心脏病。论文对代谢性治疗药物雷诺嗪抗心绞痛的作用机制及临床应用进行综述。
Myocardial isehemia often leads to a series of metabolic changes. Metabolic management of myocardial ischemia may improve myocardial functions. Therefore,metabolic intervention is a valid approach to the treatment of ischemic heart diseases. The effects of an'anlianginal metabolic agent and their mechanisms of action and clinical application were discussed here.
出处
《动物医学进展》
CSCD
2008年第11期89-92,共4页
Progress In Veterinary Medicine
关键词
心肌缺血
心肌代谢
代谢性治疗药物
雷诺嗪
心绞痛
myocardial ischemia
myocardial metabolism
metabolic agent
ranolazine
angina